DK0539503T3 - Excitatoriske aminosyreantagonister - Google Patents

Excitatoriske aminosyreantagonister

Info

Publication number
DK0539503T3
DK0539503T3 DK91913891.7T DK91913891T DK0539503T3 DK 0539503 T3 DK0539503 T3 DK 0539503T3 DK 91913891 T DK91913891 T DK 91913891T DK 0539503 T3 DK0539503 T3 DK 0539503T3
Authority
DK
Denmark
Prior art keywords
amino acid
excitatory amino
acid antagonists
antagonists
excitatory
Prior art date
Application number
DK91913891.7T
Other languages
English (en)
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0539503T3 publication Critical patent/DK0539503T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91913891.7T 1990-07-16 1991-06-17 Excitatoriske aminosyreantagonister DK0539503T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16

Publications (1)

Publication Number Publication Date
DK0539503T3 true DK0539503T3 (da) 1996-05-13

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913891.7T DK0539503T3 (da) 1990-07-16 1991-06-17 Excitatoriske aminosyreantagonister

Country Status (15)

Country Link
US (1) US5106847A (da)
EP (1) EP0539503B1 (da)
JP (1) JP3058688B2 (da)
KR (1) KR0178469B1 (da)
AT (1) ATE136295T1 (da)
AU (1) AU646686B2 (da)
CA (1) CA2087091C (da)
DE (1) DE69118539T2 (da)
DK (1) DK0539503T3 (da)
ES (1) ES2088011T3 (da)
FI (1) FI98455C (da)
GR (1) GR3019689T3 (da)
HU (1) HU216787B (da)
NO (1) NO179249C (da)
WO (1) WO1992001670A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (da) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
JPH11509847A (ja) * 1995-07-31 1999-08-31 ノボ ノルディスク アクティーゼルスカブ ヘテロ環式化合物、それらの調製及び使用
EP0929521B1 (en) * 1996-09-30 2005-11-09 Aventis Pharmaceuticals Inc. Nmda (n-methyl-d-aspartate) antagonists
DE69826881T2 (de) * 1997-03-14 2005-12-01 Smithkline Beecham Corp. Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
AU2002250256B2 (en) * 2001-03-08 2008-04-03 Emory University pH-dependent NMDA receptor antagonists
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
MX2009014216A (es) * 2007-06-29 2010-07-05 Univ Emory Antagonistas del receptor nmda para neuroproteccion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
CA2091257A1 (en) * 1990-09-10 1992-03-11 Fu-Chih Huang Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
NO930035D0 (no) 1993-01-07
CA2087091C (en) 2001-09-11
ATE136295T1 (de) 1996-04-15
NO179249C (no) 1996-09-04
AU646686B2 (en) 1994-03-03
FI930150A0 (fi) 1993-01-14
JPH05508857A (ja) 1993-12-09
ES2088011T3 (es) 1996-08-01
US5106847A (en) 1992-04-21
FI98455B (fi) 1997-03-14
FI98455C (fi) 1997-06-25
EP0539503A4 (da) 1994-03-23
DE69118539T2 (de) 1996-09-19
KR0178469B1 (ko) 1999-03-20
HUT67237A (en) 1995-03-28
JP3058688B2 (ja) 2000-07-04
FI930150A (fi) 1993-01-14
EP0539503A1 (en) 1993-05-05
HU9300100D0 (en) 1993-04-28
AU8290891A (en) 1992-02-18
NO179249B (no) 1996-05-28
GR3019689T3 (en) 1996-07-31
DE69118539D1 (de) 1996-05-09
EP0539503B1 (en) 1996-04-03
NO930035L (no) 1993-01-07
CA2087091A1 (en) 1992-01-17
WO1992001670A1 (en) 1992-02-06
HU216787B (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
DK0539503T3 (da) Excitatoriske aminosyreantagonister
ATE106401T1 (de) Benzodiazepin-analoge.
ES2078257T3 (es) Antagonistas de aminoacidos excitantes.
ATE119882T1 (de) 3-indolyl thioacetat derivate.
NO902179L (no) Fremgangsmaate for fremstilling av stimulerende aminosyre-antagonister.
ATE185969T1 (de) Potenzierung von nmda-antagonisten
ES2089511T3 (es) Dihidroquinolina antagonistas de nmda.
NO305314B1 (no) N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonister